Proven Expertise And Customized End-To-End Solutions For Your Products

IDT Biologika offers proven expertise and customized end-to-end solutions for the development and manufacturing of a wide array of products, specializing as a globally operating CDMO. With over 100 years of expertise, IDT Biologika, a part of SK bioscience, provides seamless, integrated services from process and analytical development through to drug substance manufacturing, aseptic fill/finish, and packaging.

The company's capabilities cover various modalities, including cell culture & microbial proteins, viral vectors, vaccines, gene & immune therapeutics, monoclonal antibodies, and biosimilars. Manufacturing capacities range from clinical phases I-III to commercial production, supporting a broad spectrum of technologies for vaccines and cell and gene therapy (CGT). This brochure details manufacturing scale options, including 200L to 2,000L for drug substance, and specific filling lines for vials and pre-filled syringes. IDT Biologika is an FDA, EMA, and ANVISA-approved facility, committed to driving innovation and quality.